Altria’s e-vapour profile will barely be dented by dropping pods and flavours

Altria Group has released its third-quarter results following its letter to the US Food and Drug Administration (FDA), in which the company announced it would remove most of its non-tobacco e-liquids and pods from the US market.

The results indicate that a substantial majority of the volume from Nu Mark – Altria’s “innovation company” for vapour products – will survive the commitment.

In releasing the results, Altria said: “Approximately 80% of Nu Mark’s e-vapor volume in the third-quarter of 2018 will remain on the market after removing MarkTen Elite and Apexby MarkTen pod-based products and discontinuing the sale of flavor variants of Nu Mark’s cig-a-like products, other than tobacco, menthol and mint varieties.”

Read full article
I'm already a subscriber
Author default picture

Daniel Mollenkamp

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization